Gene therapy company Adverum Biotechnologies plans to almost double its Silicon Valley headquarters and extend its existing lease terms. The deal is a sign the Bay Area biotech sector's leasing streak is not slowing down as tenants' appetites for large blocks of space bolster the region's commercial real estate market.